Linike Medical Group (LNMG) Stock Price

Linike Medical Group Price

NYSE·CLOSED
0.01
​
Market closed

Over the last 15 years Linike Medical Group grew revenue by 41.3% annually, reaching 10.68 M USD. Earnings per share have declined at 19.1% per year over the last 15 years. For Linike Medical Group, the net margin of 28.9% is up versus -200.0% a few years ago.

Linike Medical Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linike Medical Group business model & stock analysis

Linike Medical Group Ltd, headquartered in Las Vegas, Nevada, operates in the energy sector, focusing on oil and natural gas exploration. The company, listed on 17 May 2012, has subsidiaries including China Linike Medical Group Ltd and Sichuan Huarong Zhengtai Medical Technology Co., Ltd. Its primary business involves the exploration and development of energy resources.

Frequently asked questions about Linike Medical Group

Converted at the current exchange rate, the Linike Medical Group share trades at 0.01 EUR (0.01 USD).

The revenue cannot currently be calculated for Linike Medical Group.

The profit cannot currently be calculated for Linike Medical Group.

The P/E ratio cannot be calculated for Linike Medical Group at the moment.

The P/S cannot be calculated for Linike Medical Group currently.

The Eulerpool Quality Score for Linike Medical Group is 3/10.

The ISIN of Linike Medical Group is US53577J1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Linike Medical Group is LNMG. The ticker symbol is used to trade Linike Medical Group shares on the stock exchange.

Fair ValueTerminal
0.01 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
May 17, 2012
ISIN
US53577J1007
Cusip
53577J100
Market capitalization
5.01 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
7.10
P/B Ratio
0.13
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.57 %
Last updated Oct 30, 2026, 1:20 PM

Linike Medical Group Peer Group

Linike Medical Group FIGI

LNMG:US · BBG0029FBND5LNMG:PQ · BBG0029FBNT8LNMG:UV · BBG0029FBNW4